Dziennik
/
/
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
JoVE Journal
Badania Nad Rakiem
Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE.  Zaloguj się lub rozpocznij bezpłatny okres próbny.
JoVE Journal Badania Nad Rakiem
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

English

Automatycznie wygenerowane

9,386 Views

12:42 min

January 07, 2019

DOI:

12:42 min
January 07, 2019

15 Views
,

Transkrypcja

Automatically generated

Podsumowanie

Automatically generated

This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.

Powiązane Filmy

Read Article